.

BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Colorcon
Mallinckrodt
Johnson and Johnson
Argus Health
Baxter
Federal Trade Commission
Queensland Health
Chubb
Deloitte

Generated: November 20, 2017

DrugPatentWatch Database Preview

Lg Chem Ltd Company Profile

« Back to Dashboard

What is the competitive landscape for LG CHEM LTD, and what generic alternatives to LG CHEM LTD drugs are available?

LG CHEM LTD has two approved drugs.

There are seven US patents protecting LG CHEM LTD drugs.

There are eighty-three patent family members on LG CHEM LTD drugs in forty countries.

Summary for Lg Chem Ltd

International Patents:83
US Patents:7
Tradenames:2
Ingredients:2
NDAs:2
Drug Master File Entries: 6
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lg Chem Ltd
FACTIVE
gemifloxacin mesylate
TABLET;ORAL021158-001Apr 4, 2003ABRXYesYes► Subscribe► Subscribe ► Subscribe
Lg Chem Ltd
FACTIVE
gemifloxacin mesylate
TABLET;ORAL021158-001Apr 4, 2003ABRXYesYes► Subscribe► Subscribe ► Subscribe
Lg Chem Ltd
FACTIVE
gemifloxacin mesylate
TABLET;ORAL021158-001Apr 4, 2003ABRXYesYes► Subscribe► SubscribeYY ► Subscribe
Lg Chem Ltd
FACTIVE
gemifloxacin mesylate
TABLET;ORAL021158-001Apr 4, 2003ABRXYesYes► Subscribe► SubscribeYY ► Subscribe
Lg Chem Ltd
FACTIVE
gemifloxacin mesylate
TABLET;ORAL021158-001Apr 4, 2003ABRXYesYes► Subscribe► Subscribe ► Subscribe
Lg Chem Ltd
FACTIVE
gemifloxacin mesylate
TABLET;ORAL021158-001Apr 4, 2003ABRXYesYes► Subscribe► SubscribeYY ► Subscribe
Lg Chem Ltd
FACTIVE
gemifloxacin mesylate
TABLET;ORAL021158-001Apr 4, 2003ABRXYesYes► Subscribe► Subscribe ► Subscribe
Lg Chem Ltd
VALTROPIN
somatropin recombinant
INJECTABLE;INJECTION021905-001Apr 19, 2007BXRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Lg Chem Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Lg Chem Ltd
FACTIVE
gemifloxacin mesylate
TABLET;ORAL021158-001Apr 4, 2003► Subscribe► Subscribe
Lg Chem Ltd
FACTIVE
gemifloxacin mesylate
TABLET;ORAL021158-001Apr 4, 2003► Subscribe► Subscribe
Lg Chem Ltd
FACTIVE
gemifloxacin mesylate
TABLET;ORAL021158-001Apr 4, 2003► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for LG CHEM LTD drugs

Drugname Dosage Strength Tradename Submissiondate
gemifloxacin mesylate
Tablets320 mg
FACTIVE
3/4/2008

Non-Orange Book Patents for Lg Chem Ltd

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
5,633,262 Quinoline carboxylic acid derivatives having 7-(4-amino-methyl-3-oxime) pyrrolidine substituent and processes for preparing thereof► Subscribe
5,869,670 7-(4-aminomethyl-3-me thyloxyiminopyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8 -naphthyridine-3-carboxylic acid and the process for the preparation thereof► Subscribe
5,962,468 7-(4-aminomethyl-3-methyloxyiminopyrrolidin-1-yl)-1- cyclopropyl-6-fluoro-4-oxo-1, 4-dihydro-1, 8-naphthyridine-3-carboxylic acid and the process for the preparation thereof► Subscribe
6,938,154 System, method and article of manufacture for a cryptographic key infrastructure for networked devices► Subscribe
6,659,418 Positioning & locking hanging system► Subscribe
7,595,328Methods of use of quinolone compounds against pneumococcal and Haemophilus bacteria► Subscribe
6,279,257 Flush mounting security frames and hardware► Subscribe
5,840,916 Quinoline carboxylic acid derivatives having 7-(4-amino-methyl-3-oxime) pyrrolidine substituent and processes for preparing thereof► Subscribe
5,698,570 Quinoline carboxylic acid derivatives having 7-(4-amino-methyl-3-oxime)pyrrolidine substituent and processes for preparing thereof► Subscribe
7,700,617Salt of naphthyridine carboxylic acid derivative► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Lg Chem Ltd Drugs

Country Document Number Estimated Expiration
Canada2283141► Subscribe
Japan2009051851► Subscribe
Cyprus1107381► Subscribe
Austria239724► Subscribe
Turkey9902313► Subscribe
China1114959► Subscribe
Saudi Arabia1397► Subscribe
Portugal1179533► Subscribe
Hungary227536► Subscribe
South Korea100222083► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Teva
Argus Health
Boehringer Ingelheim
Dow
Novartis
Fish and Richardson
Federal Trade Commission
Queensland Health
Express Scripts
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot